SCHEMBL1123628

SCHEMBL1123628

CCCCCCCCCCCCCCCCCCCCCCC(O)C(C)CCCCCCCCCCCCCCCCC

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SPHK1 Q9NYA1 2/20 0.64
CYP2D6 P10635 2/20 0.54
LMNA P02545 2/20 0.54
GMNN O75496 1/20 0.54
POLB P06746 1/20 0.54
THPO P40225 1/20 0.54
MTOR P42345 1/20 0.54
BLM P54132 1/20 0.54
KDM4E B2RXH2 1/20 0.54
TP53 P04637 1/20 0.54
CYP1A2 P05177 1/20 0.54
CYP3A4 P08684 1/20 0.54
MAPT P10636 1/20 0.54
CETP P11597 1/20 0.54
HTT P42858 1/20 0.54
UBE2N P61088 1/20 0.54
TRPV1 Q8NER1 1/20 0.48
TRPA1 O75762 1/20 0.48
GPR84 Q9NQS5 7/20 0.46
FFAR1 O14842 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10949925 1.00 SPHK1 (0.64) SPHK1CYP2D6LMNAGMNNPOLB
SCHEMBL1122256 1.00 SPHK1 (0.64) SPHK1CYP2D6LMNAGMNNPOLB
SCHEMBL18186110 1.00 SPHK1 (0.64) SPHK1CYP2D6LMNAGMNNPOLB
SCHEMBL4956325 1.00 SPHK1 (0.64) SPHK1CYP2D6LMNAGMNNPOLB
SCHEMBL18186112 1.00 SPHK1 (0.64) SPHK1CYP2D6LMNAGMNNPOLB
SCHEMBL3697565 1.00 SPHK1 (0.64) SPHK1CYP2D6LMNAGMNNPOLB
SCHEMBL18186106 1.00 SPHK1 (0.64) SPHK1CYP2D6LMNAGMNNPOLB
SCHEMBL10952296 1.00 SPHK1 (0.64) SPHK1CYP2D6LMNAGMNNPOLB
SCHEMBL20856812 1.00 SPHK1 (0.64) SPHK1CYP2D6LMNAGMNNPOLB
SCHEMBL6154428 1.00 SPHK1 (0.64) SPHK1CYP2D6LMNAGMNNPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7538145-B2 Curable phase change compositions and methods for using such compositions XEROX CORPORATION (US) 2009-05-26 US claimed
EP-2210924-B1 Method of making a pigmented phase change ink with dispersant and synergist XEROX CORP (US) 2016-10-05 EP disclosed
EP-2236565-B1 Low polarity nano silver gels XEROX CORP (US) 2016-08-10 EP disclosed
US-9005484-B2 Low polarity nano silver gels XEROX CORPORATION (US) 2015-04-14 US disclosed
US-20130344232-A1 METHODS OF FORMING CONDUCTIVE FEATURES ON THREE-DIMENSIONAL OBJECTS XEROX CORPORATION (US) 2013-12-26 US disclosed
US-8586141-B2 Fluorescent solid ink made with fluorescent nanoparticles XEROX CORPORATION (US) 2013-11-19 US disclosed
US-20120141180-A1 SURFACE TREATMENT FOR IMPROVING THE ADHESION OF PHASE CHANGE INK ON SUBSTRATES XEROX CORPORATION (US) 2012-06-07 US disclosed
EP-2166047-B1 Solid phase change fluorescent ink and ink sets XEROX CORP (US) 2011-06-08 EP disclosed
EP-1985672-B1 Phase Change Ink Compositions XEROX CORP (US) 2011-02-09 EP disclosed
US-7857900-B2 Solid phase change fluorescent ink and ink sets XEROX CORPORATION (US) 2010-12-28 US disclosed
US-20080264288-A1 Phase change ink compositions XEROX CORPORATION. 2008-10-30 US disclosed
EP-1985672-A1 Phase Change Ink Compositions Xerox Corporation (US) 2008-10-29 EP disclosed
US-7384463-B2 Phase change ink containing amphiphilic molecule XEROX CORPORATION (US) 2008-06-10 US disclosed
US-20080100684-A1 PHASE CHANGE INK CONTAINING AMPHIPHILIC MOLECULE XEROX CORPORATION (US) 2008-05-01 US disclosed
US-20070131138-A1 Carbon black inks and method for making same XEROX CORPORATION 2007-06-14 US disclosed
US-20070119340-A1 Ink carriers containing nanoparticles, phase change inks including same and methods for making same XEROX CORPORATION 2007-05-31 US disclosed
US-20070123601-A1 Curable phase change compositions and methods for using such compositions XEROX CORPORATION (US) 2007-05-31 US disclosed
US-20070119337-A1 Black inks and method for making same XEROX CORPORATION 2007-05-31 US disclosed
US-20070119338-A1 Ink carriers, phase change inks including same and methods for making same XEROX CORPORATION 2007-05-31 US disclosed
US-20070120908-A1 Phase change inks XEROX CORPORATION (US) 2007-05-31 US disclosed